Related Experiment Video
Updated: Mar 1, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
A case of clear cell sarcoma-A rare malignancy.
Jacob Juel1, Rami Mossad Ibrahim2
1Department of Plastic and Reconstructive Surgery, Aalborg University Hospital, Aalborg, Denmark.
Clear cell sarcoma (CCS), a rare soft tissue tumor often misdiagnosed as malignant melanoma (MM), requires accurate diagnosis for optimal prognosis. This case highlights the importance of timely diagnosis to prevent tumor growth and metastasis.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Clear cell sarcoma (CCS) is a rare soft tissue tumor, often misdiagnosed due to similarities with malignant melanoma (MM).
- Immunohistochemical advancements have rendered previous classifications obsolete, yet the true incidence of CCS remains unknown, estimated at less than 1% of all sarcomas.
Purpose of the Study:
- To present a case of clear cell sarcoma (CCS) with initial misdiagnosis.
- To emphasize the importance of accurate and timely diagnosis in managing CCS.
- To discuss the treatment and follow-up of a CCS patient.
Main Methods:
- A case study of a 22-year-old patient with a gluteal mass initially suspected as infection, then malignant melanoma (MM).
- Definitive diagnosis of clear cell sarcoma (CCS) was established post-surgical removal.
- Treatment involved surgical excision with a 2cm margin, followed by PET-CT and sentinel lymph node biopsy.
Main Results:
- The patient underwent successful surgical treatment for clear cell sarcoma (CCS).
- Despite diagnostic delays, PET-CT and sentinel lymph node biopsy revealed no metastasis.
- One-year postoperative follow-up showed no signs of relapse.
Conclusions:
- Accurate and timely diagnosis of clear cell sarcoma (CCS) is crucial.
- Initial misdiagnosis can lead to delays, tumor growth, and potentially impact prognosis.
- Multidisciplinary follow-up is essential for monitoring patients with clear cell sarcoma (CCS).
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell

